Shenzhen Hepalink Pharmaceutical Group Co., Ltd. (HKG: 9989)

Shenzhen Hepalink Pharmaceutical Group Market Cap

Shenzhen Hepalink Pharmaceutical Group has a market cap or net worth of 16.63 billion as of December 3, 2024. Its market cap has decreased by -5.17% in one year.

• Market Cap: 16.63B
• Enterprise Value: 18.03B
• Revenue: 6.04B
• Ranking: n/a
• PE Ratio: n/a
• Stock Price: 4.14

Market Cap Chart

Since May 6, 2010, Shenzhen Hepalink Pharmaceutical Group's market cap has decreased from 79.74B to 16.63B, a decrease of -79.14%. That is a compound annual growth rate of -10.18%.

Market Cap History

Date	Market Cap	% Change
Dec 4, 2024	16.34B	-3.34%
Dec 29, 2023	16.91B	-12.50%
Dec 30, 2022	19.32B	-30.93%
Dec 31, 2021	27.97B	-0.50%
Dec 31, 2020	28.11B	3.27%
Dec 31, 2019	27.22B	-16.85%